An officer from the Customs and Border Protection, Trade and Cargo Division works with a dog to check parcels for fentanyl at John F. Kennedy Airport's US Postal Service facility on June 24, 2019.

An officer from the Customs and Border Protection, Trade and Cargo Division works with a dog to check parcels for fentanyl at John F. Kennedy Airport's US Postal Service facility on June 24, 2019. JOHANNES EISELE / GETTY IMAGES

Report: DHS, USPS failing in their requirements to screen for opioids in the mail

A 2018 law aimed at preventing drug producers from shipping their goods through the mail is not being implemented, IG says.

The interagency effort to stop drug distributors from sending opioids through the mail is failing to implement key reforms meant to shore up loopholes that allow such illicit materials to enter the country, according to a new review of the program. 

U.S. Customs and Border Protection, in coordination with the U.S. Postal Service and State Department, is ignoring parts of a 2018 law aimed at cracking down on international drug shippers, according to a Homeland Security Department inspector general report. The approach is leaving the nation more vulnerable to dangerous goods, such as fentanyl and other synthetic opioids, entering the country. 

The 2018 Synthetics Trafficking and Overdose Prevention (STOP) Act required foreign countries to provide "advanced electronic data" on all international packages before they reached the United States. “Advanced electronic data,” or AED, provides USPS and CBP with information about the contents of international packages before they reach the United States. A requirement for the data was already imposed on international packages coming into the country through private carriers like FedEx and UPS, but the mandate first began applying across the board to international packages arriving through USPS starting in 2021 due to the 2018 law. 

USPS collects AED from its international partners and sends it to CBP, which then places holds on packages it wants to further inspect. The Postal Service then pulls those mail pieces, and various others, and gives them to CBP for evaluation. CBP then either detains the package or clears it for further processing and delivery. 

Between fiscal 2018 and 2022, CBP made 184,000 drug seizures at USPS’ nine international mail facilities. 

Still, the IG found CBP has not followed through on key provisions of the STOP Act due to a failure of leadership and a misunderstanding of the requirements. The AED frequently contains inaccuracies, the auditors found, and CBP and USPS take few steps to validate it. Two of the nine international facilities placed holds on zero pieces of mail between 2019 and 2021. A third facility only did so in two cases in fiscal 2021, while a fourth only examined slightly more than half of the packages that had been identified to be pulled. 

The IG found CBP had not put anyone in charge of key implementation steps, had not issued any thorough guidance and that few employees went through related training. While CBP Chief Accountability Officer Henry Moark said after the report’s preliminary release that the auditors were mistaken in saying the agency did not provide adequate oversight of the AED, CBP officials told the watchdog that USPS was better suited to monitor the data’s quality. 

The IG also cited CBP for granting waivers to countries, exempting them from providing AED, without proper justification or clearance. The Biden administration issued 148 waivers in 2021 and 128 in 2022. Cargo and Conveyance Security, a CBP office, approved the waivers without getting permission from agency leadership. CCS used blank letters on USPS letterhead to sign off on the waivers, the IG found.

CBP never recorded its justifications, nor sent them to Congress as required. The agency failed to examine its own data before approving waivers and offered them to countries that were previously among the top senders of seized mail. Additionally, international mail facilities were never notified of which countries had waivers and therefore could not conduct the required extra screenings of packages originating from them. 

“By not using its internal data to evaluate the risk before granting a waiver, CBP may inadvertently grant AED waivers to high-risk countries,” the IG said. 

Congress passed the STOP Act as the opioid epidemic was ravaging communities throughout the country and international traffickers—primarily from China—were increasingly using the U.S. Postal Service to send synthetic opioids like fentanyl to American customers. While the law is still not fully implemented, it appears to have had a dramatic impact in shifting smuggling efforts away from the mail and toward the southern border.

Compared to 2018, seizures of synthetic opioids through the mail dropped by 71% and 93% in 2019 and 2020, respectively. The law appears to be having unintended consequences as well, however. After it went into effect, about 97% of interdictions were taking place in the domestic mail stream, and officials said they were increasingly finding substances like fentanyl at the southwest border.

Despite the large number of countries with waivers, DHS told Congress that as of 2022 just 5% of international mail was coming from countries not in compliance with the STOP Act. DHS seized more than 11,000 pounds of fentanyl in fiscal 2021, according to agency data, more than doubling the total from the previous year and quadrupling it from fiscal 2019. It nearly doubled that total again in fiscal 2022, seizing more than 20,000 pounds.

The IG cautioned that DHS is potentially failing to seize more materials at international mail facilities. 

“By not effectively conducting and evaluating its screening operations, addressing AED quality issues or fully implementing the STOP Act, CBP limited its ability to identify new threats in the mail environment,” the IG said. 

Moak at CBP said the agency’s top mail screening priority is preventing weapons from winding up in the hands of terrorists. He decried the IG’s report as containing “inaccurate and misleading statements,” saying it has better coordination with USPS and State than the review intimated and his agency has addressed AED quality issues. Still, CBP agreed to assign officials responsible for meeting the goals of the STOP Act, better train its employees and create a clearer process for granting waivers. 

Earlier this year, Sens. Amy Klobuchar, D-Minn., and Shelley Moore Capito, R-W.Va., introduced a bill to sunset any STOP Act waivers within five years.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.